Novo Nordisk A/S (NVO) vs Stryker Corporation (SYK)
NVO leads on 11 of 16 compared metrics.
A side-by-side comparison of Novo Nordisk A/S and Stryker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — NVO vs SYK
growth of $100 · last 30yNVO +6194.2%SYK +4866.9%NVO compounded faster
NVO SYK
NVO vs SYK: by the numbers
- •NVO is the larger company ($191.59B vs $119.03B market cap).
- •NVO trades at the lower earnings multiple (10.18 vs 34.85 P/E).
- •NVO converts more revenue to profit (37.14% vs 13.21% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs 11.42% CAGR).
- •NVO pays the higher dividend yield (4.14% vs 1.14%).
Which is better, NVO or SYK?
Metric tally: NVO 11 · SYK 5It depends on what you're optimizing for:
ValueNVO(lower P/E)
GrowthNVO(faster 5Y revenue CAGR)
IncomeNVO(higher dividend yield)
QualityNVO(higher ROIC)
Metrics side by side
Valuation
| Metric | NVO | SYK |
|---|---|---|
| P/E ratio | 10.18● | 34.85 |
| Forward P/E | — | 18.00 |
| P/S ratio | 3.78● | 4.61 |
| P/B ratio | 6.18 | 5.07● |
| PEG ratio | 8.17 | 5.16● |
| EV / EBITDA | 7.34● | 20.89 |
| FCF yield | 2.50% | 3.93%● |
Profitability
| Metric | NVO | SYK |
|---|---|---|
| Gross margin | 81.83%● | 63.67% |
| Operating margin | 45.21%● | 21.34% |
| Net margin | 37.14%● | 13.21% |
| ROE | 60.74%● | 14.52% |
| ROIC | 29.53%● | 8.53% |
Dividends
| Metric | NVO | SYK |
|---|---|---|
| Dividend yield | 4.14%● | 1.14% |
| Payout ratio | 49.80% | 40.52% |
Growth (annualized)
| Metric | NVO | SYK |
|---|---|---|
| Revenue CAGR (5Y) | 20.73%● | 11.42% |
| EPS CAGR (5Y) | 19.59%● | 14.79% |
| FCF CAGR (5Y) | -5.86% | 11.01%● |
| Total return CAGR (5Y) | 3.08% | 5.09%● |
Frequently asked
- Which is better, NVO or SYK?
- It depends on your goal. value: NVO (lower P/E); growth: NVO (faster 5Y revenue CAGR); income: NVO (higher dividend yield); quality: NVO (higher ROIC). Across all compared metrics, NVO leads 11 to 5.
- Is NVO or SYK cheaper?
- On trailing earnings, NVO is cheaper: NVO trades at a 10.18 P/E and SYK at 34.85.
- Which has grown faster, NVO or SYK?
- Over the past five years, NVO grew revenue faster — NVO at a 20.73% CAGR versus SYK at 11.42%.
- Does NVO or SYK pay a bigger dividend?
- NVO yields 4.14% and SYK yields 1.14% based on trailing dividends and the latest price.
- Is NVO or SYK more profitable?
- NVO runs the higher net margin — NVO at 37.14% versus SYK at 13.21%.
- Which has been the better investment, NVO or SYK?
- Over the past 10-year, SYK delivered the higher annualized total return — NVO at 7.78% versus SYK at 11.73%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novo Nordisk A/S P/E ratioStryker P/E ratioNovo Nordisk A/S dividend yieldStryker dividend yieldNovo Nordisk A/S ROEStryker ROENovo Nordisk A/S operating marginStryker operating marginNovo Nordisk A/S revenue growthStryker revenue growthNovo Nordisk A/S free cash flowStryker free cash flow
Novo Nordisk A/S & Stryker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.